Italia markets closed

BMY Apr 2024 59.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,03000,0000 (0,00%)
Alla chiusura: 11:06AM EDT
Schermo intero
Chiusura precedente0,0300
Aperto0,0300
Denaro0,0000
Lettera0,0000
Prezzo d'esercizio59,00
Scadenza2024-04-26
Min-Max giorno0,0300 - 0,0300
Contratto - Min-MaxN/D
Volume1
Open Interest19
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri